Emergent BioSolutions Launches NARCAN® Carrying Case and Highlights KLOXXADO® Rights
EBS•Emergent BioSolutions is partnering with Victoria’s Voice Foundation for National Naloxone Awareness Day on June 6 to distribute NARCAN® Nasal Spray and launch a compact carrying case. It highlights exclusive 2025 rights to KLOXXADO® 8 mg and an expanded portfolio of nasal spray multipacks and wall units for opioid emergency preparedness.
1. Partnership Launch
Emergent BioSolutions is teaming with Victoria’s Voice Foundation on National Naloxone Awareness Day, June 6, to distribute NARCAN® Nasal Spray, purple light bulbs, wearable promotional items and QR-coded educational materials through the Shine. Wear. Share. Care. campaign.
2. New Carrying Case
The company has introduced a compact, durable NARCAN® Nasal Spray carrying case designed to facilitate on-the-go access, complementing efforts to ensure naloxone is readily available during opioid emergencies.
3. Expanded Naloxone Portfolio
Emergent reaffirms its leadership in nasal naloxone with exclusive 2025 rights to distribute KLOXXADO® 8 mg and an expanded product lineup including multipacks, wall unit kits and convenience kits for public, business and healthcare settings.
